Seeking Alpha · ENGN · October 15, 2026

enGene Therapeutics Inc. (ENGN) Discusses Preclinical Data and Clinical Case Studies on Incorporating Surfactant Bladder Rinse into Treatment Transcript

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Seeking Alpha ↗